News Focus
News Focus
Post# of 257684
Next 10
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

Re: jq1234 post# 149462

Thursday, 09/27/2012 12:37:53 AM

Thursday, September 27, 2012 12:37:53 AM

Post# of 257684

IMGN has an ADC in ph1, IMGN853 targeting folate receptor positive OC and other solid tumors.

I believe ECYT said in their recent CC that IMGN is not using a companion diagnostic to specifically target patients. Would seem to be a disadvantage relative to ECYT's approach.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today